Lief Therapeutics is honored to be selected as one of this year’s five MedTech Innovator finalists out of more than 1,000+ incredible companies, and the winner...
The Growing Anxiety Epidemic Globally, anxiety disorders are the most prevalent mental health disorder, with over 284 million people affected each year. In the...
An estimated 264 million people worldwide live with depression. In the U.S. alone, approximately 17.3 million adults have experienced at least one major depressive...
Interest in measuring heart rate variability (HRV) as a noninvasive assessment of the autonomic nervous system has grown over the years, with increasing ease...
The COVID-19 public health emergency has contributed to a surge of stress, anxiety, and other mental health concerns for millions of people across the...
Many are unfamiliar with heart rate variability and why it’s relevant to mental health. Below, we cover the basics on this emerging gold-standard biomarker...
Lief Therapeutics’ Downtime™ digital anxiety intervention is now available as an adjunct treatment for Generalized Anxiety Disorder during the COVID-19 emergency. The patented digital...
